Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States

BACKGROUND: von Willebrand disease (VWD) can lead to serious, life-threatening bleeding events associated with substantial clinical and economic burden. OBJECTIVE: To estimate the prevalence, health care resource utilization (HCRU), and costs associated with major bleeding events in patients with VW...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Mei, Oladapo, Abiola, Wu, Yanyu, Farahbakhshian, Sepehr, Ewenstein, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394209/
https://www.ncbi.nlm.nih.gov/pubmed/33307935
http://dx.doi.org/10.18553/jmcp.2020.20327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394209/
https://www.ncbi.nlm.nih.gov/pubmed/33307935
http://dx.doi.org/10.18553/jmcp.2020.20327

Ejemplares similares